XML 47 R35.htm IDEA: XBRL DOCUMENT v3.25.3
Share-based Compensation
12 Months Ended
Sep. 30, 2025
Disclosure of terms and conditions of share-based payment arrangement [abstract]  
Share-based Compensation
27.
SHARE-BASED COMPENSATION

Selected senior executives of Birkenstock management were given an opportunity to participate in the MIP of MidCo and to indirectly invest in MidCo by purchasing a partial limited partnership interest in, and becoming a limited partner of, BK LC Manco GmbH & Co. KG, a German limited partnership, which holds certain ordinary shares in MidCo, a Luxembourg limited liability company, which is the immediate parent of Birkenstock.

In March 2023, awards for 1,197,100 shares of BK LC Manco GmbH & Co. KG were granted in five separate tranches each representing 20% of the shares. The MIP was accounted for as equity-settled share-based payment transaction in scope of IFRS 2 with a vesting period up to four years. 20% of the awards were to vest after each year of service provided with the last 20% vesting only with an occurrence of an exit. As of the grant date, the Company deemed it more likely than not that an exit event would occur more than 12 months after the grant. Therefore, for the first 20% tranche, the occurrence of an exit event was accounted for as a market condition and was included in the grant date fair value of the awards. For the remaining tranches, the occurrence of an exit event was accounted for as a non-market vesting condition. The Company considered several scenarios for the timing of the exit event and assigned appropriate probabilities to them.

The weighted average fair value of the awards granted under the MIP was €57.57.

The fair value at grant date was estimated using a DCF model and then a Black-Scholes option pricing model, weighted for the assigned probability of each exit event date scenario. The model took into account, among other things, a self-investment as well as the potential development of Birkenstock's ordinary redeemable share price. The historical volatility was derived from a peer group. The ordinary redeemable share price of €72.23 was determined based on the following assumptions:

 

 

Grant date
March 10, 2023

 

Average revenue growth rates (2023-2027) (%)

 

16.5

%

Average EBITDA margin (2023-2027) (%)

 

31.0

%

Terminal growth rate (2023-2027) (%)

 

1.5

%

After-tax discount rate (%)

 

9.9

%

Average capital expenditure investments

85.8million

 

Dividend yield (%)

 

0.0

%

Expected volatility (%)

 

34.4

%

Expected time period (years) (weighted average of the assumed exit event date scenarios)

1.1

 

Risk free interest rate (%) (weighted average of the assumed exit event date scenarios)

 

3.2

%

 

If an exit event of the Company, which is defined as initial public offering or sale, took place during the vesting period, the entire award would be immediately fully vested. Accordingly, the vesting period was variable and was subject to re-estimation each reporting date, based on expected timing of an exit event.

 

As the Company closed its IPO on October 13, 2023, the entire award fully vested during the year ended September 30, 2024, and the Company recognized €0.4 million and €3.2 million of share-based compensation expenses related to the MIP in "Selling and distribution expenses" and "General and administrative expenses", respectively. During the year ended September 30, 2023, the Company recognized €7.4 million and €58.0 million of share-based compensation expenses related to the MIP in "Selling and distribution expenses" and "General and administrative expenses", respectively. The Company incurred no expenses related to the MIP during the year ended September 30, 2025.